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Influenza virus elicits good cellular and humoral immune responses. Unlike the cytotoxic T lymphocyte response to many
other antigens, the cytotoxic T lymphocyte response to influenza virus is CD41 T cell independent, suggesting that viral
infection of antigen-presenting cells may alter their capacity to stimulate T cell responses. To clarify the role of influenza virus
in these functional alterations, we compared T cell responses to uninfected and A/PR/8/34-infected dendritic cells (DC). DC
were prepared from the bone marrow of C57BL/6 (H2b) mice and used to stimulate in vivo and in vitro alloreactive T cell
responses. In both cases, influenza virus infection increased the capacity of DC to stimulate T cell proliferation. This
enhancement was blocked by antibodies specific for neuraminidase (NA), but not hemagglutinin. Infection was not required
to observe enhanced T cell proliferation, showing that NA from exogeneous virus particles can facilitate this effect. These
results are the first to show that influenza virus alters the capacity of DC to stimulate T cell proliferation through mechanisms
mediated by viral NA. © 1999 Academic Press
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bINTRODUCTION
Infection with influenza virus evokes vigorous antibody
nd cell-mediated immune responses. However, this vi-
us escapes from antibody neutralization by selection for
rogeny with point mutations in the surface glycopro-
eins, hemagglutinin (HA) and neuraminidase (NA). Al-
hough cytotoxic T lymphocytes (CTL) are protective in a
urine model, it is clear that this response is not long-
ived in humans who can be infected with the same virus
ype, or even subtype, in sequential seasonal outbreaks
f influenza (Couch et al., 1981).
Unlike most antigens, the initiation of influenza virus-
pecific CD81 T cell responses is not dependent on
D41 T cells. The evidence for this is that there is no
ffect of CD41 T cell depletion on the generation of
irus-specific CTL in response to influenza virus infection
n mice (Allan et al., 1990). Also, good CTL responses are
enerated in vitro in the absence of CD41 T cells when
endritic cells (DC) are infected with influenza virus
Ridge et al., 1998). The “help” supplied by CD41 T cells
s not by engagement with naive CD81 T cells, but rather
hrough provision of activation signals to antigen-pre-
enting cells (APC) (Ridge et al., 1998). The observation
hat influenza virus can bypass this help suggests that
his virus directly alters the functional capacity of DC, the
rimary cell type used for antigen presentation. It may be
hat viral infection regulates key cellular components or
hat viral proteins themselves mediate a change in the
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: (410) 955-7159. E-mail: meichelb@jhsph.edu.
427nteraction between DC and naive T cells. One can
ypothesize that either HA or NA could effect such a
hange. For example, HA, which is synthesized de novo
nd expressed on the surface of virus infected-APC, may
acilitate association with T cells by binding to sialic
cids. Sialic acids, however, can inhibit intermolecular
nd intercellular interactions (Pilatte et al., 1993; Varki,
997), and therefore removal of sialic acids from the
urface of the APC by viral NA may enhance their contact
ith T cells.
The restrictive role of sialic acids in antigen presenta-
ion to T cells was first reported by Cowing and Chap-
elaine (1983), who showed that MHC class II molecules
rom mouse adherent cells, which possess a strong
otential to stimulate T cells, were less sialylated than
hose from B cells. Both MHC class I and class II mole-
ules as well as adhesion molecules are glycoproteins
ith terminal sialic acids that influence binding of their
igands (Boog et al., 1989; Cowing and Chapdelaine,
983; Cullen et al., 1982; Diamond et al., 1991). An exam-
le of regulation of adhesion by sialic acids is CD43
sialophorin or leukosialin), a major cell-surface sialogly-
oprotein that functions as an anti-adhesion molecule. It
egulates cell-to-cell interactions depending upon the
tate of sialylation (Ardman et al., 1992; de Smet et al.,
993). Monoclonal antibodies against CD43 enhance the
apacity of DC to form clusters with, and activate, T
ymphocytes (Fanales-Belasio et al., 1997). These obser-
ations raise the possibility that the capacity to present
ntigen and stimulate T cell responses may be regulated
y sialylation of cell surface molecules.Exogeneous bacterial NA has been used in both in
0042-6822/99 $30.00
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428 OH AND EICHELBERGERitro (Boog et al., 1989; Gallart et al., 1997) and in vivo
Rhodes et al., 1995a) experiments to increase immune
esponses. It is therefore reasonable to propose that
uring influenza virus infection, viral NA could desialylate
ell surface glycoconjugates and consequently alter the
egulatory processes mediated by sialic acids. Sialic
cids may regulate immune responses by contributing to
he negative cell surface charge, by blocking specific cell
urface molecules from binding to T cell ligands, or by
locking Schiff-base formation between carbonyl groups
n APC and amine groups on the responding T cells
Rhodes et al., 1995b). Other ways that viral NA may
ontribute to the immune response include activation of
omplement (Lambre et al., 1982) and TGF-b (Schultz-
herry and Hinshaw, 1997) or alteration of lectin-binding
olecules (Pilatte et al., 1993; Varki, 1997).
To clarify the role of virus glycoproteins in initiation of
he immune response, we examined whether influenza
irus infection alters the capacity of DC to stimulate T
ells. Our experimental design included a comparison of
he allogeneic T cell response to uninfected and A/PR/
/34 (PR8)-infected DC. In this report, we demonstrate
hat PR8-infected DC stimulate greater alloreactive T cell
roliferation than uninfected DC. We also show that viral
A, but not HA, contributes to this enhanced prolifera-
ion. This effect of viral NA may explain why immune
esponses to influenza virus are particularly vigorous
nd suggests that NA may facilitate the generation of
D41 T cell-independent influenza-specific CTL re-
ponses.
RESULTS AND DISCUSSION
llogeneic T cell proliferation is enhanced by PR8
nfection of DC
DC are effective APC that express high levels of MHC
lass I and II as well as costimulatory molecules. DC
rom spleen, lymph node, or bone marrow can stimulate
llogeneic mixed-lymphocyte reactions and sensitize na-
ve T cells in vivo and in vitro (Steinman, 1991). We
ompared the proliferation of T cells to allogeneic DC
hat were either uninfected or infected with PR8 at 5
CID50/cell. Various numbers of H2
b DC were used to
timulate 3 3 105 H2d T cells. Our results showed in-
reased proliferation to PR8-infected DC when less than
3 104 DC were used to stimulate 3 3 105 T cells/well
Fig. 1). The average percentage increase in proliferation
or six assays was 102% (with 1 3 103 DC/well), 74% (with
3 103 DC/well), 18% (with 10 3 103 DC/well), and 4%
with 50 3 103 DC/well).
When 5 3 104 or more DC were added per well, this
nhanced proliferation was no longer observed. This
ay reflect inhibitory agents such as inducible nitric
xide (Bonham et al., 1996), IL-10, or TGF-b secreted by
C or T cells under these conditions. However, sinceery small numbers of DC can stimulate immune re- cponses in vivo, and DC comprise less than 1% of the
otal cell population of lymph nodes or spleen, the en-
anced proliferation that is observed at lower numbers
f DC is likely to be physiologically relevant.
Uninfected and PR8-infected DC were also used to
timulate T cells in vivo. Either 5 3 105 or 1 3 105
ninfected, or PR8-infected, H2b DC were used to immu-
ize H2d mice intraperitoneally. CD41 T cells were iso-
ated from these mice, as well as from mice that had not
een immunized, and tested for their ability to respond to
he immunizing alloantigen by measuring proliferation to
rradiated H2b splenocytes. The results showed greater
D41 T cell proliferation with cells from mice that had
een immunized with PR8-infected DC than uninfected
C (Table 1). This difference was evident in both the
aseline proliferation without restimulation in vitro and
he proliferation in restimulated cultures. Since equal
umbers of T cells were added in each well, this differ-
nce suggests either that a greater number of cells was
rimed to alloantigen in vivo or that the proliferative
apacity of each cell was enhanced by priming in the
resence of influenza virus.
The T cells isolated from the spleens of each of these
roups of immunized mice were in an activated state,
ince they incorporated [3H]thymidine even in the ab-
ence of restimulation. This is shown in Table 1, with T
FIG. 1. Allogeneic T cell proliferation to uninfected and influenza virus
PR8)-infected DC. DC were prepared by culture of bone marrow from
57BL/6 (H2b) mice for 8 days. Cells were infected with PR8 at 5 m.o.i.
or 4 h. Different numbers of DC were mixed with 3 3 105 T cells from
he spleen of BALB/c (H2d) mice. Plates were pulsed with 1 mCi/well of
3H]thymidine for 24 h before harvesting. Data presented are means
SD of quadruplicates. These results are representative of numerous
xperiments.ells from mice immunized with 105 DC incorporating a
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429VIRAL NA ALTERS T CELL RESPONSESean of 10,141 counts per minute (cpm), whereas CD41
cells from untreated naive mice incorporated 413 cpm.
iral NA contributes to the enhanced allogeneic
roliferation to PR8-infected DC
A reasonable hypothesis is that both viral HA and NA
ontribute to this enhanced response. To test this, allo-
eneic cultures were set up in the presence or absence
f antibody specific for H1 or N1, the subtypes in PR8. It
as confirmed that these antibody preparations had
eutralizing activity; i.e., anti-H1 inhibited viral agglutina-
ion, while anti-N1 blocked viral NA enzyme activity (data
ot shown). Figure 2 shows alloreactive T cell prolifera-
ion in the absence or presence of these polyclonal
ntibodies. Neither anti-H1 nor anti-N1 antibodies had
n effect on allogeneic T cell proliferation stimulated by
ninfected DC. There was also no change when T cells
ere cultured with PR8-infected DC in the presence of
nti-H1. It was thought that viral HA could possibly in-
rease the avidity between T cells and APC by binding to
ialic acid receptors on T cells, but these results dem-
nstrate that this is not the case.
Unlike anti-H1, anti-N1 antibody significantly de-
reased the T cell proliferation stimulated by virus-in-
ected DC. Approximately 30% of the response was in-
ibited by anti-N1 antibody so that the proliferation to
irus-infected DC was similar to that stimulated by unin-
ected DC. One mechanism by which viral NA contrib-
tes to T cell proliferation may be that changes in DC
urface charge (when sialic acids are removed) increase
TABLE 1
Proliferation of Allogeneic CD41 T Cells (H2d) That Are Primed in
Vivo by Immunization with Uninfected or PR8-Infected DC (H2d)
Number of DC/mouse in
primary immunizationa
Proliferationb of CD41 T cells from
mice immunized with
Untreated DC PR8-infected DC
ith in vitro restimulation
1 3 105 11,756 23,125
5 3 105 16,616 33,341
ithout in vitro restimulation
1 3 105 10,141 11,846
5 3 105 14,022 16,340
a H-2b DC were cultured from C57BL/6 bone marrow as described
nder Materials and Methods. These cells were either uninfected or
nfected with PR8 at 10 TCID50/cell. Both groups were irradiated,
ashed, and then inoculated ip into 8-week-old BALB/c mice. After 3
eeks, CD41 T cells were cultured with or without 105 irradiated H-2b
plenocytes/well. Cells from mice that had not been immunized gave
ean cpm of 985 (after in vitro culture with 105 H-2b splenocytes/well)
nd 413 (without addition of H-2b splenocytes).
b Proliferation was measured by incorporation of [3H]thymidine. Data
resented are the mean counts per minute (cpm) of quadruplicate
ultures.he avidity of DC for T cells. To demonstrate that there is delease of sialic acids from infected cells and that this is
nhibited by anti-N1, we quantitated sialic acid in the
upernatants of DC. The supernatants of 106 DC that had
een infected with PR8 for 2 h contained 1212 6 88 ng/ml
ialic acid, whereas the same number of uninfected DC
r cells infected with PR8 in the presence of anti-N1
ontained 87 6 12 and 121 6 14 ng/ml, respectively.
To support the idea that viral NA enhances the allo-
eactive response by altering cell surface charge and
herefore increases the avidity for untreated cells, DC
nd/or T cells were treated with an exogenous source of
acterial NA, and proliferation was measured (Fig. 3).
he T cell proliferation to uninfected DC is shown in Fig.
A and to infected DC in Fig. 3B. When uninfected DC
ere treated with 1 mU/ml of bacterial NA for 1 h, the
esponse was enhanced to a magnitude similar to that of
he response to PR8-infected DC. Proliferation to unin-
ected DC was also enhanced when T cells were treated
ith bacterial NA. However, when both DC and T cells
ere treated with bacterial NA separately and then
ixed together, T cell proliferation was decreased.
hese results support the hypothesis that cell surface
harge contributes to the response: when both cells are
reated with NA, the resulting charge on each cell would
e equivalent and consequently there would be no
hange in avidity or T cell response.
FIG. 2. Antibodies to influenza virus NA block the enhanced alloge-
eic T cell proliferation. Antibodies against hemagglutinin (anti-H1) and
euraminidase (anti-N1) were added into each well at 1 mg/ml during
nfection with PR8 as well as during mixed DC/T cell culture. The
esults are shown for 103 uninfected or PR8-infected DC added into
ach well containing 3 3 105 spleen T cells. Thymidine uptake was
easured by as described in the legend to Fig. 1. Data presented are
eans 6SE for six separate experiments. The statistical significance of
ifferences in proliferation in the presence or absence of antibody was
etermined by Wilcoxon Rank test. *P , 0.005 (n 5 6).
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430 OH AND EICHELBERGERIn contrast, T cell proliferation to infected DC after
reatment with bacterial NA gave different results. The T
ell proliferation to virus-infected DC was not changed
y additional treatment of DC with bacterial NA. How-
ver, the response to virus-infected DC was further in-
reased by NA treatment of T cells. This was unexpected
s it was anticipated that under these conditions, sialic
cids would be removed from both cell types, resulting in
o change in avidity between DC and T cells. This sug-
ests that the removal of sialic acids from the surface of
C by viral NA may be incomplete and hence there are
till charge differences that result in enhanced DC–T cell
vidity. This is unlikely since quantitation of sialic acids
n the supernatants of DC treated with bacterial NA was
ess than after PR8 infection (892 6 32 and 1212 6 88
FIG. 3. Effect of V. cholerae NA on allogeneic T cell proliferation to
ninfected (A) or PR8-infected DC (B). Both influenza virus-infected and
ninfected DC, as well as T cells, were treated with NA (1 mU/ml) for
h at 37°C and then used in a mixed lymphocyte reaction. Thymidine
ptake was measured as described in the legend to Fig. 1. Data
resented are means 6SD (n 5 4). The statistical significance of
ifferences in proliferation was determined by Wilcoxon Rank test.
ingle and double asterisks indicate P , 0.005 (n 5 4) when T cell
roliferation was compared to responses to uninfected DC without NA
reatment. *** P , 0.001 (n 5 4) when T cell proliferation was compared
o responses to PR8-infected DC without NA treatment.g/ml, respectively). This result therefore suggests that tther mechanisms, in addition to the change in charge,
ontribute to the NA-dependent proliferative response.
Other mechanisms that could contribute to the NA-
nhanced response include physical and chemical
hanges that result from desialylation. The degree of
ialylation may regulate the function of key costimulatory
r adhesion molecules on DC that enhance the interac-
ion with T cell ligands. In addition to facilitating physical
nteractions between molecules, removal of sialic acids
ay permit chemical reactions, such as the oxidation of
reterminal sugars and formation of Schiff bases that
lay a role in T cell activation (Rhodes et al., 1995b).
hen both DC and T cells were treated with bacterial
A, the response to virus-infected DC was still greater
han the response to uninfected DC. This supports the
dea that influenza virus infection of DC alters the re-
ponse through qualitative differences at the DC surface
hat change stimulatory capacity.
Costimulatory and adhesion molecules provide impor-
ant contacts that influence T cell responses. To deter-
ine whether PR8 infection of DC changes expression of
hese, uninfected and infected cells were immuno-
tained with monoclonal antibodies specific for B7-1,
7-2, and ICAM-1. The DC prepared in vitro with GM-
SF-conditioned medium are considered “immature”
ince they express DC-specific antigens such as CD11c,
ut modest levels of B7-1, B7-2, and ICAM-1. PR8 infec-
ion of these DC resulted in increased immunostaining
ith antibodies to B7-1 and B7-2, as well as ICAM-1 (Fig.
). This may reflect increased expression of these mol-
cules or greater avidity of antibody to the desialylated
lycoproteins. Either of these mechanisms could facili-
ate interaction with the respective ligands or T cells and
ead to increased T cell stimulation.
To compare the role of viral glycoproteins NA and HA
ith costimulators B7-1, B7-2, and ICAM-1 to allogeneic
cell responses, combinations of antibodies were
dded to the mixed lymphocyte reaction, and prolifera-
ion was measured (Table 2). When DC were infected
ith virus, antibodies to B7-1 and B7-2 result in diminu-
ion of the proliferative response, whereas the response
o uninfected DC was decreased very little by anti-B7-1
ntibody. This may reflect increased binding of B7-1 to its
igand (CD28 or CTLA4) due to structural changes in the
bsence of sialic acids or increased expression in virus-
nfected cells. The increased contribution of B7-1 to stim-
lation by PR8-infected DC was also demonstrated by
he reduced proliferation observed when anti-B7-1 was
dded to cultures containing antibodies to B7-2, H1, and
1. Consequently, proliferation to PR8-infected DC was
educed by 95% when antibodies to B7-1, B7-2, ICAM-1,
1, and N1 were added to the cultures, whereas the
roliferation to uninfected DC was reduced by only 50%
ith the same mixture. Future studies will determine
hether sialylation or expression of B7-1 contributes tohe interaction of T cells with virus-infected cells.
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431VIRAL NA ALTERS T CELL RESPONSESnfection is not required for NA to enhance T cell
roliferation
The source of NA to enhance T cell proliferation may
e either (a) influenza NA expressed on the surface of
nfected cells or (b) NA on the surface of virions prior to
nfection. To demonstrate that NA is present on the
urface of infected cells, enzyme activity on influenza
irus-infected DC was compared with that on uninfected
C. The enzyme activity on DC infected with NWS-Mvi, a
irus that lacks viral NA activity, was also measured. Our
esults showed that PR8-infected DC have greater NA
ctivity than uninfected or NWS-Mvi-infected DC (Table
). Enzyme activity was consistently greater on cells
nfected with NA-deficient NWS-Mvi than uninfected
ells, indicating that the activity of cellular NA may be
ncreased by influenza virus infection.
To determine whether virus infection was required for
FIG. 4. Influenza virus infection increases expression of costimula-
ory molecules, B7-1 and B7-2, as well as ICAM-1 on DC. DC were
repared from B6 bone marrow cultures. Cells were infected with PR8
t 5 or 50 m.o.i. for 4 h, stained with specific monoclonal antibodies,
nd analyzed by flow cytometry. Staining of infected cells (dotted line
m.o.i.; thick line 50 m.o.i. infection) is overlaid with staining of unin-
ected (thin line) cells.nhanced T cell proliferation, DC were treated with UV-nactivated PR8. Culture of UV-treated PR8 on MDCK
ells in the presence of trypsin yielded no virus, showing
hat this virus cannot replicate. However, UV inactivation
id not reduce NA activity significantly. Enhanced T cell
roliferation was evident even when DC were treated
ith UV-inactivated virus (Fig. 5A), showing that de novo
ynthesis of NA was not required to effect this change.
his was further supported by the lack of enhanced
roliferation to PR8-infected DC that were treated with
ntibody or inhibitor to neutralize NA activity during the
irst 4 h of infection only (Fig. 5B). Also, proliferation was
TABLE 2
Effect of Antibodies on Allogeneic T Cell Proliferation
to Uninfected or Influenza Virus-Infected DC
Antibodya specificity
% proliferationb of allogeneic
T cells to
Uninfected
DC
PR8-infected
DC
one 100 100
7-2 75 6 6.8 70 6 7.3
7-1 93 6 7.2 83 6 8.4
CAM-1 78 6 6.1 82 6 6.8
1 105 6 9.4 101 6 9.2
1 99 6 7.1 67 6 3.9
1 1 N1 102 6 9.0 70 6 7.1
7-1 1 B7-2 70 6 7.2 71 6 4.7
7-1 1 B7-2 1 ICAM-1 48 6 2.8 57 6 6.1
7-2 1 N1 1 H1 75 6 6.9 43 6 2.8
7-2 1 B7-1 1 H1 1 N1 72 6 4.8 20 6 3.4
CAM-1 1 B7-2 1 B7-1 1 H1 1 N1 46 6 0.7 4 6 0.3
a Antibodies to B7-1, B7-2, and ICAM-1 were added to each well with
final concentration of 2.0 mg/ml. Antibodies to H1 and N1 were added
t 1 mg/ml.
b 1 3 103 DC (H2b) that were influenza virus infected or not were
ultured with 1 3 105 T cells (H2d) in each well. Thymidine uptake was
easured described in the legend to Fig. 1. Data presented are means
SD of triplicates.
TABLE 3
Comparison of NA Activity on Uninfected
and Influenza Virus-Infected DC
Treatment of DCa Neuraminidase activity (mU)b
Uninfected 83.4 6 5.3c
PR8-infected 241.6 6 12.9 (P , 0.001)
NWS-Mvi-infectedd 98.3 6 8.8 (P , 0.005)
a DC were obtained from day 8 bone marrow cell cultures. NA was
easured as described under Materials and Methods using 1 3 103
ells in each reaction. NA activity was measured after a 4-h infection
ith PR8 or NWS-Mvi.
b One unit is the enzyme activity that hydrolyzes 1 mmol N-acetyl-
euraminosyl-D-lactose within 1 min at 37°C.
c Data are means 6SE (n 5 4).
d Neuraminidase-deficient influenza virus.
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432 OH AND EICHELBERGERnhanced when DC were treated with PR8 in the pres-
nce of antibodies to HA (Fig. 5B). Since anti-H1 blocks
nfection with PR8, the enhanced T cell response to
hese DC must be due to NA activity on virions during the
irst 4 h of incubation.
Thus, infection is not required to elicit an altered T cell
esponse. Since productive infection with influenza virus
equires cleavage of HA by a trypsin-like enzyme that is
ot ubiquitous, it is likely that large numbers of nonin-
ectious virus particles are associated with cells within
he respiratory tract, including DC that carry this antigen
omplex to the draining lymph node. Provided that NA is
ctive, association of virus with DC may therefore result
n an enhanced T cell response in vivo. This may seem to
e a disadvantage to the virus; however, for an RNA virus
ith great capacity to mutate and escape immune neu-
FIG. 5. Infection is not required for NA to enhance T cell proliferation.
A) Allogeneic T cell proliferation to PR8-infected or UV-inactivated
R8-treated DC. (B) Allogeneic T cell proliferation to DC treated with
ntibodies to HA (anti-HA) or NA (anti-NA) or with NA inhibitor (2,3-
ehydro-2-deoxy-N-acetylneuraminic acid) during PR8 infection. Anti-
odies and inhibitor were also added to DC that were not infected with
R8. In both experiments A and B, thymidine uptake was measured as
escribed in the legend to Fig. 1. Data presented are means 6SD (n 5
). Proliferation that is marked with an asterisk is statistically different
P , 0.005) from proliferation without treatment, as determined by
ilcoxon Rank test.ralization, the role of NA in virus release and dissemi- cation (Palese et al., 1974) is likely to outweigh the impact
f viral NA on immune induction.
Although our results show that viral NA is a major
ontributor to the change in immune response that is
easured in vitro, other factors may also contribute to
his observation. For example, changes in expression or
tructure of costimulatory molecules (Fig. 4, Table 2) or
nhanced activity of cellular NA (Table 3) may also facil-
tate T cell proliferation.
The function and specificity of eukaryotic NA are
oorly understood. Our results show that in vitro devel-
ped bone marrow-derived DC have their own cellular
A and this enzyme activity is increased by influenza
irus infection (Table 3). It is predicted that cellular NA
lays an important role in immunity since a NA gene is
ocated within the MHC locus (Peters et al., 1981), is
p-regulated early after T cell activation (Landolfi et al.,
985; Sumiko and Nariuchi, 1988), and is required for the
nduction of IL-4 from T cells (Chen et al., 1997). When
C were treated with a nonspecific NA inhibitor, allo-
eactive T cell proliferation to PR8-infected DC was even
ess than when stimulated with uninfected DC (Fig. 5B),
uggesting that cellular NA does play a role in DC func-
ion by removing sialic acids to facilitate interactions with
cells. This contribution of cellular NA was also evident
s a small but significant decrease in T cell proliferation
hen uninfected DC were treated with this NA inhibitor
Fig. 5B).
Although others have reported that influenza virus in-
ection of DC enhances T cell proliferation (Ridge et al.,
998), this report is the first to show that viral NA con-
ributes to the enhanced T cell response observed when
C are treated with a low dose of virus. Our current
xperiments define the in vivo contribution of viral NA to
he CD41-independent CTL response to influenza and
xplore the use of influenza NA as a vaccine adjuvant.
MATERIALS AND METHODS
irus preparations
PR8 virus was cultured in 10-day embryonated chicken
ggs. The infected allantoic fluid was harvested and
liquots were stored at 270°C. A NA-deficient NWS-Mvi
irus was kindly provided by Dr. Gillian Air (University of
klahoma Health Sciences Center). A stock of NWS-Mvi
as cultured in the presence of both trypsin (0.2 mg/ml)
nd Vibrio cholerae NA (1 mU/ml) in MDCK cells (Liu and
ir, 1993). Virus was inactivated by UV irradiation. The
A activities of live and inactivated viruses were similar.
Virus titers were determined by infection of MDCK
ells. Before inoculation with virus, cell monolayers were
ashed with serum-free DMEM (Gibco) twice. Tenfold
ilutions of virus were made in serum-free DMEM. One
undred microliters of each virus dilution was added into
uadruplicate wells of a 96-well plate containing MDCK
ells. After 1 h, 100 ml of DMEM medium supplemented
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433VIRAL NA ALTERS T CELL RESPONSESith 3% BSA and 0.2 mg/ml of trypsin was added to the
ulture plates and incubated at 37°C. For NWS-Mvi, the
inal culture medium also contained 1 mU/ml of V. chol-
rae NA (Boehringer Mannheim, Mannheim, Germany).
fter 3 days, 25 ml of the supernate from each well was
ransferred into a round-bottom 96-well plate. PBS (25 ml)
nd washed 0.5% chicken red blood cells (50 ml) were
dded and hemagglutination was observed after 30 min
t room temperature. The inverse of the dilution at which
0% of the wells showed hemagglutination was recorded
s the TCID50. The titer of each of the virus stocks (PR8
nd NWS-Mvi) was 109 TCID50/ml. Heat-inactivated and
V-inactivated PR8 did not contain any infectious virus.
ice
Five to 6-week-old female C57BL/6 (H2b) and BALB/c
H2d) mice were purchased from The Jackson Laboratory
Bar Harbor, ME) and housed at Johns Hopkins Univer-
ity. They were used at 6 to 14 weeks of age.
endritic cells
Femurs and tibias from C57BL/6 mice were removed,
ashed with PBS, and transferred into a dish containing
erum-free RPMI 1640 (Life Technologies, Gaithersburg,
D). Both ends of each bone were removed, and the
arrow was flushed out using 2 ml of serum-free RPMI
640 in a syringe with a 25-gauge needle. Red blood
ells (RBC) were lysed with 0.85% NH4Cl and the remain-
ng cell suspension was washed with RPMI 1640 con-
aining 1% glutamine, 10% FCS, and penicillin–streptomy-
in–amphotericin B (complete medium). Cells were fi-
ally resuspended at 5–10 3 105 cells/ml in complete
edium containing 200 units/ml of GM-CSF and cultured
n plastic petri dishes. After 3 days, an additional 10 ml of
he same medium was added. On days 5 and 7 of culture,
onadherent cells were pelleted, resuspended in an
qual volume of fresh medium, and returned to culture.
onadherent cells were used on day 8 of culture. The
ells were identified as DC by microscopic examination
large cells with dendritic extensions), FACS analysis
stained with antibodies to cell surface molecules N418,
7-1, B7-2, MHC class II), and the excellent capacity to
timulate allogeneic T cell responses.
cells
T cells from BALB/c mouse spleen were prepared by
epletion of B cells and macrophages. Spleen cell sus-
ensions were made and RBC were lysed. Cells were
hen washed and resuspended in serum-free RPMI 1640
t 1 3 107 cells/ml. Rat anti-mouse B220 (RA3-6B2) and
nti-mouse Mac1 (M1/70) antibodies (PharMingen, San
iego, CA) were added at 10 mg/ml and incubated on ice
or 30 min before washing with medium. Anti-rat Ig
oated magnetic beads (Dynal, Oslo, Norway) were
dded and used to remove B220- and Mac1-positive dells following the manufacturer’s instructions. The re-
aining cells were counted and then used in experi-
ents. In some experiments, CD81 T cells were removed
y inclusion of rat anti-mouse CD8 antibody (53-6.7,
harMingen) before incubation with magnetic beads.
irus infection
Influenza virus PR8 and NWS-Mvi were used to infect
ultured DC. Virus (5 ml of virus stock) was added into
ubes containing 1 3 106 of DC in 2 ml of PBS, giving a
ultiplicity of infection (m.o.i.) of 5. After a 1-h incubation
t 37°C, 10 ml of complete medium was added and
ncubated for 3 h at 37°C. Uninfected DC were treated in
he same way, except that virus was not added. In some
xperiments, 5 mM 2,3-dehydro-2-deoxy-N-acetylneura-
inic acid (Boehringer Mannheim), a NA inhibitor, or 1
g/ml goat anti-H1 or anti-N1 antibodies (NIH, Bethesda,
D) was added during the first 4 h of infection.
n vitro allogeneic T cell proliferation
Virus-infected and uninfected DC were irradiated
3000 rad), washed, and serially diluted in complete me-
ium. T cells were resuspended at 3 3 106 cells/ml in
omplete medium. Equal volumes (100 ml) of DC (H2b)
nd T cells (H2d) were plated in quadruplicate wells in a
6-well round-bottom tissue culture plate (Costar, Cam-
ridge, MA). After 48 h of culture at 37°C, 1 mCi of
3H]thymidine (DuPont, Boston, MA) was added into each
ell. After a further 24 h of culture, cells were harvested
nto filters (Skatron, Lier, Norway). Filters were dried and
ndividual disks were placed into scintillation vials. Scin-
illation cocktail was added (3 ml/vial) and samples were
hen counted using a Beckman LS 6500 beta counter.
he average counts per minute of quadruplicate cultures
as calculated.
To determine the role of costimulatory molecules, anti-
7-1 (1G10), anti-B7-2 (GL1), and anti-ICAM-1 (3E2) anti-
odies (PharMingen) were added into the mixed cell
ultures at 2 mg/ml. Goat anti-H1 and anti-N1 were
dded at 1 mg/ml throughout the culture period in some
xperiments.
n vivo alloreactive T cell proliferation
To stimulate alloreactive T cells in vivo, 5 3 105 or 1 3
05 uninfected or PR8-infected H2b DC were used to
mmunize H2d mice intraperitoneally (i.p.). After 3 weeks,
he spleens were removed and CD41 T cells were iso-
ated and cultured at 3 3 105 cells/well with either no
urther stimulation or with irradiated C57BL/6 spleno-
ytes (105 cells/well). There was no further exposure to
irus at this stage. Proliferation was measured by incor-
oration of [3H]thymidine into quadruplicate cultures as
escribed above.
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434 OH AND EICHELBERGEReuraminidase treatment
Uninfected DC, influenza virus (PR8)-infected DC, and
cells were treated with purified NA from V. cholerae.
ells were resuspended in PBS at 1 3 106 cells/ml and
ncubated with 1 mU/ml of bacterial NA for 1 h at 37°C.
he cells were then washed twice with PBS. The viability
f cells was not changed by NA treatment. Control cells
ere maintained under identical conditions in the ab-
ence of NA.
etermination of NA activity
The activity of NA on influenza virus-infected and un-
nfected DC was measured using a modification of a
reviously reported method (Gubareva et al., 1997;
ambre et al., 1989). Briefly, 50 ml of cell suspension
ontaining 5 3 104 DC in 0.1 M sodium phosphate buffer,
H 5.9, was mixed with 50 ml of 0.2 mM 29-(4-methylum-
elliferyl)-a-D-N-acetylneuraminic acid in the same
uffer. After 50 min at RT, the reaction was stopped by
ddition of 150 ml of 0.1 M glycine buffer, pH 10.7, con-
aining 25% ethanol. The fluorescence of released MU
as determined with a Wallac fluorometer (excitation
avelength 335 nm; emission wavelength 460 nm).
uantitation of sialic acid
One million DC were resuspended in 1 ml RPMI and
ncubated without additional treatment or with PR8 or
acterial NA, for 2 h at 37°C. In one set of experiments,
nti-N1 (2 mg/ml) was added to the cells. Cells were
elleted and 400 ml of each supernatant was used in an
ssay that followed a modified method of Mrkoci et al.
1996). As a standard, N-acetylneuraminic acid was se-
ially diluted in PBS. The supernatant or standard was
ixed with 150 ml sodium metaperiodate (25 mM in 125
M H2SO4). After a 30-min incubation at 37°C, 100 ml
odium metaarsenite (6% in 0.5 M HCl) and 100 ml thio-
arbituric acid (6% (wt/vol) adjusted to pH 8–9 with
aOH) were added. This mixture was incubated for 30
in at 95°C. Dimethyl sulfoxide (500 ml) was added to
ach reaction tube and 200 ml was aliquoted into a
6-well plate for reading at A550 on a microplate reader
Molecular Devices, Palo Alto, CA). All chemicals were
urchased from Sigma (St. Louis, MO).
low cytometry and antibodies
Single-cell suspensions were counted and 2–5 3 105
ells were incubated with 10% normal mouse serum for
t least 20 min. After washing, the corresponding mono-
lonal antibodies against B7-1, B7-2, and ICAM-1 were
ixed with cells for 20 min at 4°C. Cells were washed
ith PBS containing 1% BSA and subsequently stained
ith fluorescein isothiocyanate-conjugated goat anti-rat
ntibodies (PharMingen). Following a second wash step,
04 cells were examined by flow cytometry (EPICS ELITE,
oulter).nalysis of data
The significance of the difference between mean val-
es was compared using the nonparametric Wilcoxon
ank test. Unless otherwise specified, all data are ex-
ressed as means 6SD.
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